Sign in
4

Changes in Ownership

Edesa Biotech, Inc. Filed Acc 0001144204-18-014749

Options or other derivatives

  • EVP, Corporate Development acquired 30,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
BAXTER GREGORY T. EVP, Corporate Development 2018-03-12 Grant or award · Share Option (Right To Buy) +30,000 30,000 D
Loading xslF345X03/tv488518_4.xml…